Brooge Energy Limited f/k/a Brooge Holdings Limited f/k/a Twelve Seas investors: Please contact the Portnoy Law Firm to recover your losses; April 5, 2024 deadline
April 08, 2024 18:32 ET
|
Portnoy Law
LOS ANGELES, April 08, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Brooge Energy Limited f/k/a Brooge Holdings Limited f/k/a Twelve Seas Investment Company (NASDAQ: BROG). investors that a...
Amylyx Pharmaceuticals, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 9, 2024 deadline
April 08, 2024 18:24 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 08, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Amylyx Pharmaceuticals, Inc....
Amylyx Pharmaceuticals, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 9, 2024 deadline.
March 28, 2024 14:15 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 28, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Amylyx Pharmaceuticals, Inc....
AMLX Class Action Alert: Robbins LLP Reminds Investors of Pending Lead Plaintiff Deadline – April 9, 2024 – in Amylyx Pharmaceuticals, Inc. Class Action
March 21, 2024 18:06 ET
|
Robbins LLP
Robbins LLP is investigating the allegations that Amylyx Pharmaceuticals, Inc. (AMLX) misled investors regarding RELYVRIO's commercial prospects.
Amylyx Pharmaceuticals, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 9, 2024 deadline
March 12, 2024 20:41 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 12, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Amylyx Pharmaceuticals, Inc....
AMLX STOCK NEWS: Lead Plaintiff Deadline is Approaching in Class Action Against Amylyx Pharmaceuticals, Inc.; Contact Robbins LLP for Information
March 05, 2024 16:16 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations that Amylyx Pharmaceuticals, Inc. (AMLX) Misled Investors Regarding the Viability of its Drug for Treating ALS
AMLX Class Action Alert: Robbins LLP Reminds Shareholders of Lead Plaintiff Deadline in the Class Action Against Amylyx Pharmaceuticals, Inc.
February 20, 2024 15:18 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations Against Amylyx Pharmaceuticals Inc.
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Amylyx Pharmaceuticals, Inc. (AMLX)
February 12, 2024 22:28 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations Against Amylyx Pharmaceuticals, Inc.